Weight Loss & MetabolicPeer Reviewed
Effects of semaglutide on one-year medical costs among patients with obesity or overweight in US real world setting.
Authors (9)
Prachi AroraNovo Nordisk Inc, Plainsboro, NJ, USA.
Wojciech MichalakNovo Nordisk Inc, Plainsboro, NJ, USA.
Zhenxiang ZhaoNovo Nordisk Inc, Plainsboro, NJ, USA.
Megan FiasconaroGenesis Research Group, Hoboken, NJ, USA.
Expert review of pharmacoeconomics & outcomes research
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
HCRU and costsObesity and overweightobesity-related complicationsreal-worldsemaglutide
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.